WHO ICTRP trial
Potassium handling in chronic hemodialysis patients in response to higher…
NL-OMON55533 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON55533 |
|---|---|
| Public title | Potassium handling in chronic hemodialysis patients in response to higher dialysate potassium |
| Scientific title | Potassium handling in chronic hemodialysis patients in response to higher dialysate potassium - K+ Balance in Hemodialysis |
| Primary sponsor | Academisch Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | CKD-5D End-Stage-Renal-Disease;10029149;CKD-5D;End-Stage-Renal-Disease |
| Interventions | Hemodialysis patients will be treated for 4 weeks using widely used dialysate solutions as part of standard care containing potassium either 2 mmol/L or 4 mmol/L in random order. ;CKD-5D;Dialysate potassium;Serum potassium;Total body K+… |
| Registration date | Sep 27, 2021 |
| Target size | 30 |
| Secondary IDs | NL66478.018.18 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: